Eyepoint Pharmaceuticals Inc (EYPT) Stock Analysis

Eyepoint Pharmaceuticals Inc (EYPT) is a publicly traded company in the HEALTHCARE sector. It trades at $12.53, carries a market capitalization of $1.10B. This page summarizes the public market data, fundamentals, and frequently asked questions for EYPT, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $12.53
• Market Cap: $1.10B
• EPS: $-3.51
• 52-Week High: $19.11
• 52-Week Low: $7.94

Market Sentiment

Eyepoint Pharmaceuticals Inc currently has a Bullish sentiment score of 0.17.

About Eyepoint Pharmaceuticals Inc

EyePoint Pharmaceuticals, Inc. is a pioneering biopharmaceutical company based in Watertown, Massachusetts, dedicated to developing innovative therapeutics for serious ocular diseases. Utilizing its proprietary micro-insert technology, the company specializes in sustained-release drug delivery systems designed to meet significant unmet medical needs in ophthalmology. With a robust pipeline targeting conditions such as retinal diseases, EyePoint is strategically poised for growth in major mark...

GNG Research Analysis

GNG Research scores Eyepoint Pharmaceuticals Inc (EYPT) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for EYPT.

Frequently Asked Questions

Does EYPT pay dividends?

Eyepoint Pharmaceuticals Inc (EYPT) does not currently pay a regular dividend.

What is EYPT's market cap?

Eyepoint Pharmaceuticals Inc (EYPT) has a market capitalization of $1.10B with a current stock price of $12.53.